UPSTREAM BIO
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.
UPSTREAM BIO
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.upstreambio.com
Total Employee:
11+
Status:
Active
Contact:
+1-800-539-0289
Email Addresses:
[email protected]
Total Funding:
408 M USD
Technology used in webpage:
Squarespace Hosted Twitter Timeline
Similar Organizations
BioInvenu
BioInvenu is a biotechnology research company.
Celavie Biosciences
Celavie Biosciences is a biotechnology research company.
EternaTear
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Integrated BioTherapeutics
AIntegrated BioTherapeutics is a focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
Ladder Therapeutics
Ladder Therapeutics is a biotechnology research company.
PvP Biologics
PvP Biologics is developing an oral enzyme for the treatment of celiac disease.
SoyMeds
SoyMeds is a biotechnology research company
Current Advisors List
Current Employees Featured
Founder
Investors List
Wellington Management
Wellington Management investment in Series B - Upstream Bio
Access Biotechnology
Access Biotechnology investment in Series B - Upstream Bio
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series B - Upstream Bio
HBM Partners
HBM Partners investment in Series B - Upstream Bio
Decheng Capital
Decheng Capital investment in Series B - Upstream Bio
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Upstream Bio
Samsara BioCapital
Samsara BioCapital investment in Series B - Upstream Bio
Enavate Sciences
Enavate Sciences investment in Series B - Upstream Bio
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Upstream Bio
Altshuler Shaham
Altshuler Shaham investment in Series B - Upstream Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2024-04-02 | Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team |
Official Site Inspections
http://www.upstreambio.com Semrush global rank: 5.26 M Semrush visits lastest month: 1.47 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Upstream Bio"
Team - Upstream Bio
As SVP, People & Culture, at Upstream Bio, Lisa Fiering is focused on building the company’s team and maintaining a strong company culture. She brings to Upstream 30 years of …See details»
Upstream Bio - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +1-800-539-0289; Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the …See details»
Upstream Bio - LinkedIn
Upstream Bio | 5,971 followers on LinkedIn. Developing treatments for inflammatory diseases | We are advancing verekitug, a clinical-stage monoclonal antibody targeting an upstream driver …See details»
Upstream Bio Company Profile 2024: Stock …
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240173405-A1: Pharmaceutical compositions comprising anti-human tslp receptor antibodies and methods of using the sameSee details»
Upstream Biosciences - Overview, News & Similar companies
Apr 2, 2024 View Upstream Biosciences (www.upstreambio.com) location in Massachusetts, United States , revenue, industry and description. ... Upstream Biosciences has announced …See details»
Upstream Bio Information - RocketReach
Upstreambio.com; 3 978808XXXX; 978631XXXX; 978392XXXX; View Similar People. Related Companies Mobile Heartbeat. 113 $16.7m ElevateBio. 598 Entasis Therapeutics. 20 $17.2m …See details»
Investor FAQs — Upstream Bio
Find answers to common investor questions about Upstream Bio.See details»
Upstream Bio - Craft
Upstream Bio has 5 employees at their 1 location and $200 m in total funding,. See insights on Upstream Bio including office locations, competitors, revenue, financials, executives, …See details»
About - Upstream Bio
At Upstream Bio, we are developing treatments for inflammatory diseases. We are developing verekitug, the only known antagonist currently in development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP).See details»
Upstream Bio - Company Profile - Tracxn
Jun 8, 2022 Upstream Bio ranks 6th among 262 active competitors. 104 of its competitors are funded while 48 have exited. Overall, Upstream Bio and its competitors have raised over …See details»
Join Us - Upstream Bio
Join us in our mission to develop verekitug to be the first approved antagonist of the TSLP receptor to benefit patients suffering from severe inflammatory diseases that are underserved …See details»
Upstream Bio Inc, UPB:NSQ profile - FT.com - Financial Times
Dec 2, 2024 Upstream Bio Inc (UPB:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Upstream Bio - workinbiotech.com
Upstream Bio is dedicated to leveraging advanced scientific techniques in cellular and molecular biology to address inflammatory and allergic diseases. Their mission focuses on developing …See details»
News Releases — Upstream Bio
May 15, 2024 View Upstream Bio releases, including company news, investor relations information and more.See details»
Upstream Bio Announces Closing of $293 Million Upsized Initial …
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with …See details»
Upstream Bio Announces $200M Series B Financing to Advance …
Jun 8, 2023 [email protected]. Media Contact MacDougall Advisors Carolyn Noyes [email protected]. 1 World Health Organization, website, 2023 2 American Lung …See details»
Upstream Bio, Inc. (UPB) Stock Price, Quote & News - Stock Analysis
Website https://upstreambio.com. Full Company Profile. Financial Performance. Financial numbers in USD Financial Statements. Analyst Forecast. According to 4 analysts, the average …See details»
Upstream Bio Launches with $200M Series A Financing to Advance …
Jun 2, 2022 Clinical-stage program UPB-101 targets the TSLP receptor, a cytokine receptor positioned upstream in the inflammatory cascade with the potential to impact multiple …See details»